Menu Back toElectronic Labeling: Where are we Now and What are the Next Steps in the World?

DIA 2021 Global Annual Meeting

Electronic Labeling: Where are we Now and What are the Next Steps in the World?

Session Chair(s)

Rie  Matsui, RPh

Rie Matsui, RPh

  • Senior Director, Regional Labeling Head for APAC
  • Pfizer R&D Japan G.K., Japan
The most updated eLabeling initiatives in the US, EU, Canada, and Japan, and the trends for eLabeling in emerging markets will be shared. The possibility of the convergence of the eLabeling initiatives will be discussed in the digital health.v
Learning Objective : Describe the most updated electronic labeling initiatives in the US, EU, Canada, Japan, and emerging countries; Discuss the possibility of the convergence for electronic labeling across regions.


Shinobu  Uzu, MSc

eLabeling Updates in Japan and Collaboration with Asia Countries

Shinobu Uzu, MSc

  • Senior Executive Director
  • Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Elizabeth  Scanlan, PhD, MSc

Electronic Product Information (ePI) in the EU: Progress and the Road Ahead

Elizabeth Scanlan, PhD, MSc

  • Scientific Communication Officer, Stakeholders and Communication Division
  • European Medicines Agency, Netherlands
Christine  Wood, PhD

Behind the Scenes in Implementing eLabeling: COVID-19 Vaccine Label Development During a Global Pandemic

Christine Wood, PhD

  • Global Labeling TA Director (Respiratory and Immunology)
  • AstraZeneca, United Kingdom